Get startedLog in
    Picture of AnaptysBio logo

    ANAB — AnaptysBio News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    AnaptysBio abandons eczema drug development after mid-stage trial failure

    Picture of AnaptysBio logoAnaptysBio
    11/12/2024 13:36
    Dec 11 (Reuters) - AnaptysBio  ANAB.O  said on Wednesday
that it would discontinue the development of its eczema drug
after it failed to meet the main and secondary goals of a
mid-stage trial.

 (Reporting by Puyaan Singh in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Puyaan.Singh@thomsonreuters.com;))

    Recent news on AnaptysBio

    See all news